Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211, USA.
Cold Spring Harb Perspect Med. 2013 Jan 1;3(1):a009498. doi: 10.1101/cshperspect.a009498.
Cystic fibrosis transmembrane conductance regulator (CFTR) is an ATP-gated anion channel with two remarkable distinctions. First, it is the only ATP-binding cassette (ABC) transporter that is known to be an ion channel--almost all others function as transport ATPases. Second, CFTR is the only ligand-gated channel that consumes its ligand (ATP) during the gating cycle--a consequence of its enzymatic activity as an ABC transporter. We discuss these special properties of CFTR in the context of its evolutionary history as an ABC transporter. Other topics include the mechanisms by which CFTR gating is regulated by phosphorylation of its unique regulatory domain and our current view of the CFTR permeation pathway (or pore). Understanding these basic operating principles of the CFTR channel is central to defining the mechanisms of action of prospective cystic fibrosis drugs and to the development of new, rational treatment strategies.
囊性纤维化跨膜电导调节因子(CFTR)是一种 ATP 门控阴离子通道,具有两个显著的区别。首先,它是唯一已知的 ATP 结合盒(ABC)转运体,是一种离子通道——几乎所有其他的都作为运输 ATP 酶发挥作用。其次,CFTR 是唯一的配体门控通道,在门控循环中消耗其配体(ATP)——这是其作为 ABC 转运体的酶活性的结果。我们将在 CFTR 作为 ABC 转运体的进化历史背景下讨论 CFTR 的这些特殊性质。其他主题包括 CFTR 门控如何通过其独特调节域的磷酸化调节,以及我们当前对 CFTR 渗透途径(或孔)的看法。理解 CFTR 通道的这些基本工作原理是确定潜在囊性纤维化药物作用机制的核心,也是开发新的、合理的治疗策略的关键。